Anemia drugs receive new warning labels

Jamie Sheller
Attorney
(877) 245-6841 Ext 475
Posted by Jamie ShellerNovember 16, 2007 10:58 AM

Earlier this week, the FDA issued new warning labels to Procrit, Epogen, and Aranesp. These drugs are used to increase hemoglobin levels in patients with chronic renal failure and cancer. Changes to the warnings for patients with cancer include a risk of shortened survival and tumor progression when the dosage reaches a certain level. The warning changes for patients with chronic renal failure include removing claims of improved qualitify of life. To read more about these changes visit this site.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Philadelphia

InjuryBoard Philadelphia RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Meet your local
Philadelphia, Pennsylvania
InjuryBoard Firm
Sheller, P.C. (877) 245-6841 Ext. 475 www.sheller.com
google
Personal Injury Lawyers Serving: Statewide Pennsylvania, Philadelphia, Norristown, Cheltenham, Chester, Drexel Hill, Folsom, Havertown, King of Prussia, Levittown, Radnor, Springfield, Swarthmore, West Chester, Willow Grove
1528 Walnut Street3rd Floor, Philadelphia, Pennsylvania 19102 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address